Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseas

By: C. Michael White, University of Connecticut, The Conversation

Outlets: The Conversation

Published: October 30, 2025

Words: 1,328

Last Updated: 3 weeks, 5 days ago

Body Text Preview

By C. Michael White, University of Connecticut

If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October 2025 about an extensive recall of thousands of bottles of atorvastatin, the generic version of Lipitor.

Both generic atorvastatin and brand-name Lipitor contain the same active ingredient, atorvastatin calcium, and are considered bioequivalent by the Food and Drug Administration. This medication is the No. 1-selling drug …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.

Email Us